GNS Healthcare

The company said it plans to use the technology to derive clinical insights from the large-scale proteomic datasets generated by its SomaScan platform.

Using data from the Parkinson's Progression Markers Initiative, GNS Healthcare identifies genetic and molecular markers of rapid motor progression.

Swedish Cancer Institute has enlisted machine-learning technology vendor GNS Healthcare to model patient-specific breast cancer tumor data.

The companies plan to use machine learning and simulation to study disease drivers and identify existing and new therapies, focusing first on cardiovascular disease.

Most recently, Celgene has licensed the GNS platform for internal use and made an undisclosed equity investment in the company.

The firm will use the funding, which comes from both new and existing investors, to develop new cloud-based solutions for precision medicine.

GNS Healthcare and the Multiple Myeloma Research Foundation to use GNS' informatics solutions to explore genomic and clinical data from the CoMMpass study.

Robert Hoyt has joined GenomeQuest's board of directors
Hoyt is currently Eximo's chief operating officer. Prior to that, he was the general manager of Endeca Technologies which sold to Oracle in 2011.

Knome has hired Josh Forsythe as its new vice president of sales and marketing. He joins the company after 10 years at Golden Helix, where held several positions including VP of business development, VP of sales and marketing, and director of marketing.

Pages

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.